LTRYW
Translational Development Acquisition Corp.
NASDAQ · Consumer Cyclical · Gambling, Resorts & Casinos · US
$0.00
−27.78%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$0.00
From 52W high−91.97%
Volume271561.00
Market cap$4847.11
P/E (TTM)—
P/S (TTM)0.0x
Div yield—
Key dataOct 19, 2026
Open
$0.00
From 52W high
−91.97%
Volume
271561.00
Market cap
$4847.11
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−2.3x
P/E (TTM)
—
RSI (14)
36.2
MomentumView details →
1D Return
−27.78%
YTD Return
−68.63%
Similar companies
Latest newsMore news →
ProLogium and Translational Development Acquisition Corp. announced a $50 million committed primary capital investment from existing ProLogium shareholders to support their business combination that will make ProLogium a publicly listed company.84d agoTranslational Development Acquisition Company announced that ProLogium has filed an F-4 with the SEC as part of their planned de-SPAC merger.106d ago